Triamcinolone-Assisted Pars Plana Vitrectomy for Proliferative Vitreoretinopathy Secondary to Toxocariasis.

Accession number;04A0276147
Title;Triamcinolone-Assisted Pars Plana Vitrectomy for Proliferative Vitreoretinopathy Secondary to Toxocariasis.
Author; IINO HIROYUKI (Fac. Medicine, Jikei Univ. School of Medicine, JPN) NAMIKI MIKA (Fac. Medicine, Jikei Univ. School of Medicine, JPN) NAGAI YUKIKO (Fac. Medicine, Jikei Univ. School of Medicine, JPN) SAKAI TSUTOMU (Fac. Medicine, Jikei Univ. School of Medicine, JPN) KOZAKI KEN'ICHI (Fac. Medicine, Jikei Univ. School of Medicine, JPN) YOSHITOSHI TAKASHI (Fac. Medicine, Jikei Univ. School of Medicine, JPN) KAMATA YOSHIO (Fac. Medicine, Jikei Univ. School of Medicine, JPN) AKAO NOBUAKI (Tokyo Medical and Dental Univ., Graduate School, JPN)
Journal Title;Journal of the Eye
Journal Code:Y0754A
ISSN:0910-1810
VOL.21;NO.3;PAGE.385-388(2004)
Figure&Table&Reference;FIG.4, REF.8
Pub. Country;Japan
Language;Japanese
Abstract;We describe a case of toxocariasis and proliferative vitreoretinopathy that benefited from vitrectomy. The patient, a 29-year-old female with toxocariasis, developed a dense vitreous floater, vitreous traction bands with disc neovascularization associated with macular dragging, and visual obscuration in her right eye. Subsequently, the condition slowly worsened despite systemic steroids. Triamcinolone-assisted pars plana vitrectomy relieved the proliferative changes and the visual obscurations. Enzyme-linked immunosorbent assay (ELISA) of toxocara titer from anterior chamber and vitreous fluid respectively showed 0.259 and 0.623 as mean absorbance. Proliferative vitreoretinopathy may develop as a complication of toxocariasis. Triamcinolone-assisted pars plana vitrectomy may be of benefit in such cases. (author abst.)